TransMedics Group, Inc. (TMDX)
USD 60.88
(-7.34%)
USD 60.88
(-7.34%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.02 Million | -45.81 Million | -28.86 Million | -30.26 Million | -32.28 Million | -25.98 Million |
| Net Income | -25.02 Million | -36.23 Million | -44.21 Million | -28.74 Million | -33.54 Million | -23.75 Million |
| Depreciation & Amortization | 8.27 Million | 3.47 Million | 1.81 Million | 1.57 Million | 1.22 Million | 769 Thousand |
| Deferred income taxes | -1.66 Million | - | 2.28 Million | -431 Thousand | 336 Thousand | 1 Million |
| Stock-based compensation | 19.79 Million | 10.32 Million | 6.87 Million | 2.41 Million | 854 Thousand | 144 Thousand |
| Change in working capital | -44.34 Million | -26.75 Million | 3 Million | -5.58 Million | -1.62 Million | -4.32 Million |
| Other non-cash items | 29.93 Million | 3.37 Million | 1.36 Million | 511 Thousand | 475 Thousand | 177 Thousand |
| Investing Cash Flow | -193.95 Million | 54.51 Million | 29.26 Million | -41.59 Million | -60.5 Million | 12.3 Million |
| Investments in PPE | -179.05 Million | -11.9 Million | -3.51 Million | -455 Thousand | -165 Thousand | -418 Thousand |
| Acquisitions | -14.89 Million | 107 Thousand | -32.78 Million | 41.14 Million | 60.33 Million | - |
| Investment purchases | - | -10.49 Million | -72.02 Million | -121.79 Million | -82.37 Million | - |
| Sales/Maturities of investments | - | 76.91 Million | 104.81 Million | 80.65 Million | 22.03 Million | 12.72 Million |
| Other Investing Activities | -27.21 Million | -107 Thousand | 32.78 Million | -41.14 Million | -60.33 Million | 12.72 Million |
| Financing Cash Flow | 400.41 Million | 167.92 Million | 1.39 Million | 75.54 Million | 92.72 Million | 22.06 Million |
| Debt repayment | -393.3 Million | -22.45 Million | - | -2.24 Million | - | -9.07 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 955 Thousand | 509 Thousand | 419 Thousand | 357 Thousand | - | - |
| Common Stock Issuance | 7.11 Million | 145.46 Million | 1.39 Million | 75.54 Million | 97.36 Million | 46 Thousand |
| Other Financing Activities | -52.07 Million | 145.46 Million | 1.39 Million | 75.54 Million | -4.64 Million | 31.14 Million |
| Accounts receivables | -33.81 Million | -21.67 Million | 840 Thousand | -218 Thousand | -3.16 Million | -2.51 Million |
| Accounts payables | 6.95 Million | -3.27 Million | 5.09 Million | -5.8 Million | 3.44 Million | 164 Thousand |
| Inventory | -28.09 Million | -8.02 Million | -4.89 Million | -1.74 Million | -4.12 Million | -2.69 Million |
| Other working capital | 10.6 Million | 6.21 Million | 1.96 Million | 2.17 Million | 2.21 Million | 721 Thousand |
| Cash at beginning of period | 201.18 Million | 26.08 Million | 25.08 Million | 20.59 Million | 20.74 Million | 12.43 Million |
| Cash at end of period | 394.81 Million | 201.68 Million | 26.08 Million | 25.08 Million | 20.59 Million | 20.74 Million |
| Capital Expenditure | -179.05 Million | -11.9 Million | -3.51 Million | -455 Thousand | -165 Thousand | -418 Thousand |
| Effect of forex changes on cash | 193 Thousand | -1.02 Million | -797 Thousand | 803 Thousand | -85 Thousand | -82 Thousand |
| Net cash flow / Change in cash | 193.63 Million | 175.6 Million | 999 Thousand | 4.48 Million | -149 Thousand | 8.3 Million |
| Free Cash Flow | -192.08 Million | -57.72 Million | -32.38 Million | -30.72 Million | -32.45 Million | -26.4 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.21 Million | 12.19 Million | 12.19 Million | 4.03 Million | -25.02 Million | -25.42 Million |
| Depreciation & Amortization | 5.17 Million | 4.59 Million | 4.4 Million | 3.7 Million | 8.27 Million | 1.89 Million |
| Deferred income taxes | - | - | - | -120 Thousand | -1.66 Million | -1.27 Million |
| Stock-based compensation | 7.94 Million | 7.64 Million | 6.87 Million | 5.72 Million | 19.79 Million | 5.18 Million |
| Change in working capital | -11.24 Million | 177 Thousand | -28.09 Million | -5.55 Million | -44.34 Million | -15.53 Million |
| Other non-cash items | 769 Thousand | 15.69 Million | 42.92 Million | 523 Thousand | 29.93 Million | 28.28 Million |
| Investing Cash Flow | -47.76 Million | -23.76 Million | -44.17 Million | -41.81 Million | -193.95 Million | -149.82 Million |
| Investments in PPE | -48.2 Million | -23.76 Million | -44.17 Million | -41.81 Million | -179.05 Million | -134.93 Million |
| Acquisitions | 441 Thousand | - | - | 14.89 Million | -14.89 Million | -14.89 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 441 Thousand | - | - | -42.1 Million | -27.21 Million | -27.21 Million |
| Financing Cash Flow | 7.86 Million | 10.64 Million | 3.18 Million | 924 Thousand | 400.41 Million | 1.52 Million |
| Debt repayment | - | - | - | -393.3 Million | -393.3 Million | -14.62 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 1.42 Million | - | 638 Thousand | 571 Thousand | 955 Thousand | - |
| Common Stock Issuance | -13.82 Million | 10.64 Million | 3.18 Million | 924 Thousand | 7.11 Million | 1.52 Million |
| Other Financing Activities | 7.86 Million | 10.64 Million | 3.18 Million | 924 Thousand | -52.07 Million | -13.09 Million |
| Accounts receivables | -8.81 Million | 757 Thousand | -18.4 Million | -2.81 Million | -33.81 Million | -11.13 Million |
| Accounts payables | -36 Thousand | 3.81 Million | -2.03 Million | 416 Thousand | 6.95 Million | 2.86 Million |
| Inventory | -4.55 Million | -2.31 Million | -5.61 Million | -7.06 Million | -28.09 Million | -10.05 Million |
| Other working capital | 2.16 Million | -2.07 Million | -2.03 Million | 3.9 Million | 10.6 Million | 2.78 Million |
| Cash at beginning of period | 363.25 Million | 350.21 Million | 394.81 Million | 427.11 Million | 201.18 Million | 582.96 Million |
| Cash at end of period | 330.59 Million | 362.75 Million | 350.21 Million | 394.81 Million | 394.81 Million | 427.61 Million |
| Capital Expenditure | -48.2 Million | -23.76 Million | -44.17 Million | -41.81 Million | -179.05 Million | -134.93 Million |
| Effect of forex changes on cash | 386 Thousand | -62 Thousand | -173 Thousand | 292 Thousand | 193 Thousand | -177 Thousand |
| Net cash flow / Change in cash | -32.65 Million | 12.53 Million | -44.59 Million | -32.29 Million | 193.63 Million | -155.35 Million |
| Free Cash Flow | -41.34 Million | 1.95 Million | -47.6 Million | -33.51 Million | -192.08 Million | -141.8 Million |
1409
GRND
0179
1269
9950
ELSTR